Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$554M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$435M |
| 3 |
CERN
Cerner Corp
CERN
|
+$282M |
| 4 |
Norfolk Southern
NSC
|
+$238M |
| 5 |
ExxonMobil
XOM
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.35B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$966M |
| 4 |
NVIDIA
NVDA
|
+$768M |
| 5 |
AT&T
T
|
+$594M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.52% |
| 2 | Technology | 7.24% |
| 3 | Financials | 6.69% |
| 4 | Healthcare | 6.46% |
| 5 | Industrials | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
CALL
Nektar Therapeutics
NKTR
$2.48B
| $4.27M | ﹤0.01% |
52,773
+32,146
| +156% | +$4.76M |
|
3052
Array Technologies
ARRY
$707M
| $4.26M | ﹤0.01% |
378,373
-105,236
| -22% | -$1.18M |
|
3053
PUT
GameStop
GME
$8.02B
| $4.26M | ﹤0.01% |
102,400
+40,000
| +64% | +$1.18M |
|
3054
Evolus
EOLS
$587M
| $4.26M | ﹤0.01% |
+379,982
| New | +$3.24M |
|
|
TLMDW
3055
CALL
DELISTED
SOC Telemed, Inc. Warrants
TLMDW
| $4.26M | ﹤0.01% |
5,258,000
+355,100
| +7% | +$187K |
|
3056
RLJ Lodging Trust
RLJ
$1.75B
| $4.26M | ﹤0.01% |
302,378
-714,195
| -70% | -$10M |
|
|
YALA
3057
Yalla Group
YALA
$837M
| $4.25M | ﹤0.01% |
948,808
+36,166
| +4% | +$209K |
|
|
AHRT
3058
AH Realty Trust
AHRT
$488M
| $4.25M | ﹤0.01% |
290,800
+70,324
| +32% | +$1.01M |
|
3059
Altimmune
ALT
$605M
| $4.25M | ﹤0.01% |
697,160
+588,302
| +540% | +$4.33M |
|
3060
Viavi Solutions
VIAV
$9.02B
| $4.25M | ﹤0.01% |
+263,969
| New | +$4.35M |
|
3061
Tootsie Roll Industries
TR
$3.1B
| $4.24M | ﹤0.01% |
136,529
-144,843
| -51% | -$4.32M |
|
|
SRRA
3062
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $4.24M | ﹤0.01% |
+132,187
| New | +$3.79M |
|
|
PWPPW
3063
CALL
DELISTED
Perella Weinberg Partners Warrant
PWPPW
| $4.22M | ﹤0.01% |
2,099,932
+687,986
| +49% | +$1.76M |
|
3064
Cable One
CABO
$145M
| $4.22M | ﹤0.01% |
2,881
+2,034
| +240% | +$3.1M |
|
3065
Lindsay Corp
LNN
$1.16B
| $4.21M | ﹤0.01% |
26,785
-113,000
| -81% | -$15.6M |
|
3066
iShares MSCI Brazil ETF
EWZ
$8.16B
| $4.2M | ﹤0.01% |
111,193
-113,907
| -51% | -$3.68M |
|
|
CNCE
3067
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $4.2M | ﹤0.01% |
1,245,412
-103,817
| -8% | -$329K |
|
3068
Seres Therapeutics
MCRB
$51.3M
| $4.2M | ﹤0.01% |
29,464
-33,760
| -53% | -$5.19M |
|
3069
Eagle Bancorp
EGBN
$840M
| $4.2M | ﹤0.01% |
73,579
-91,627
| -55% | -$5.47M |
|
3070
Reliance Steel & Aluminium
RS
$19.8B
| $4.19M | ﹤0.01% |
22,874
-138,407
| -86% | -$23.9M |
|
|
TLGY
3071
DELISTED
TLGY Acquisition Corporation Class A Ordinary Share
TLGY
| $4.18M | ﹤0.01% |
+420,193
| New | +$4.17M |
|
|
AFMD
3072
DELISTED
Affimed
AFMD
| $4.18M | ﹤0.01% |
95,727
+18,691
| +24% | +$812K |
|
|
BFAC.U
3073
DELISTED
Battery Future Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
BFAC.U
| $4.17M | ﹤0.01% |
415,000
-71,757
| -15% | -$718K |
|
3074
Xenon Pharmaceuticals
XENE
$5.81B
| $4.17M | ﹤0.01% |
136,326
+45,705
| +50% | +$1.37M |
|
3075
PUT
C4 Therapeutics
CCCC
$474M
| $4.17M | ﹤0.01% |
+171,700
| New | +$4.17M |
|
Similar funds
Israel Englander's Q1 2022 Portfolio in Review
As of Q1 2022, Israel Englander held 8,193 positions worth $189B, down 4.1% from $197B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Israel Englander's Q1 2022 filing shows 1,491 new, 2,450 increased, 2,453 reduced and 1,365 closed positions. Its largest new stake was Mondelez International: 1,780,636 shares worth $112M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.35B.
By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, up from 58% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q1 2022 buy was Mondelez International: 1,780,636 shares worth $112M.
- Israel Englander added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $554M increase.
- Israel Englander's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.35B.
- Israel Englander fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $532M.
- Israel Englander's ten largest holdings make up 24% of its $189B portfolio in Q1 2022.
- Israel Englander opened 1,491 new positions and closed 1,365 in Q1 2022.
- Israel Englander's portfolio value fell 4.1% quarter-over-quarter to $189B.
Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.